Most Recent Articles by Anna Olechowska
Treatment with brexpiprazole as adjunctive antidepressant therapy was safe and effective in patients with major depressive disorder.
In pediatric patients with bipolar I depression, long-term treatment with lurasidone 20 mg/day is effective in reducing depressive symptoms.
In pediatric patients with ADHD, treatment with dasotraline 4 mg/day was effective in treating a range of ADHD-related symptoms and behaviors.
Younger patients treated with antipsychotics after experiencing a first episode of psychosis are at an increased risk for metabolic syndrome and cardiovascular disease.
Longitudinal associations between diabetes and cognitive decline have been reported.
More Articles by Anna Olechowska
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Correctional Psychiatry: Challenges and Rewards
- Color Vision Impairment in Schizophrenia May Be Due to Medication
- Sleep Disorders Linked to Nonaffective Psychosis in Young Adults
- Lithium May Treat Children With Bipolar Disorder, but Pediatric Studies Are Lacking
- Improvement in Guidelines for Monitoring Patients Receiving Lithium Essential
- The Opioid System: The Foundation for Social Risk and Reward
- Nomophobia: The Modern-Day Pathology
- Is Mandatory Reporting of Child Maltreatment in the Best Interests of the Child?
- Those Left Behind: Working With Suicide-Bereaved Families
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Associations Among Gender Nonconformity, Mental Distress, and Substance Use Among High School Students
- Digital Cognitive Therapy Eases Daytime Effects of Insomnia
- Predicting Poststroke Depression: Biomarkers and Beyond
- Sexual Harassment, Assault Tied to Women's Health Issues
- Daily Drinking Associated With Increased Mortality Risk